Association of hypomagnesemia with inferior survival in a phase III, randomized study of cetuximab plus best supportive care versus best supportive care alone: NCIC CTG/AGITG CO.17

M.M. Vickers, C.S. Karapetis, D. Tu, C.J. O'Callaghan, T.J. Price, N.C. Tebbutt, Guy Van Hazel, J.D. Shapiro, N. Pavlakis, P. Gibbs, J. Blondal, U. Lee, J.M. Meharchand, R.L. Burkes, S.H. Rubin, J. Simes, J.R. Zalcberg, M.J. Moore, L. Zhu, D.J. Jonker

    Research output: Contribution to journalArticlepeer-review

    37 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)953-960
    JournalAnnals of Oncology
    Issue number4
    Publication statusPublished - 2013

    Cite this